NeuroPace (NPCE) Payables (2020 - 2026)

NeuroPace has reported Payables for 7 years, with the latest figure at $4.2 million in Q2 2026.

• On a quarterly basis, Payables fell 10.95% year-over-year to $4.2 million in Q2 2026; TTM through Jun 2026 was $4.2 million, a 10.95% decrease from a year earlier, with the FY2025 full-year figure at $1.8 million, down 39.88% from the prior year.
• Payables was $4.2 million for Q2 2026 at NeuroPace, down from $4.5 million in the prior quarter.
• The five-year high for Payables was $4.7 million in Q2 2025, with the low at $1.2 million in Q3 2022.
• Average Payables over 5 years is $2.7 million, with a median of $2.3 million recorded in 2022.
• The largest YoY upside for Payables was 112.5% in 2025 against a maximum downside of 39.88% in 2025.
• Over 5 years, Payables stood at $2.1 million in 2022, then climbed by 8.62% to $2.3 million in 2023, then increased by 26.67% to $3.0 million in 2024, then sank by 39.88% to $1.8 million in 2025, then surged by 136.71% to $4.2 million in 2026.
• The last three Payables figures came in at $4.2 million (Q2 2026), $4.5 million (Q1 2026), and $1.8 million (Q4 2025), per Business Quant data.